False
November 13, 2025
Phase I trial finds intranasal, adjuvanted recombinant H5 influenza vaccine primes strong mucosal and systemic immunity – subsequent injection boost yields cross-clade protection against multiple H5N1 viruses.
1 min read
November 13, 2025
In stroke patients with dysphagia, the default practice of crushing tablets could increase residue, reduce efficacy, and raise aspiration risk...
5 min read
November 13, 2025
We get the lowdown on Kindeva’s new, multi-use facility in Bridgeton and trends in the market.
November 12, 2025
Engineered tRNAs are redefining precision RNA therapeutics, restoring protein function in diseases caused by nonsense mutations, and bridging the gap between RNA and gene editing technologies.
5 min read
November 12, 2025
Our latest news roundup reports on Novartis’ new radioligand facility in California, new tech for boosting AAV yields, and MeiraGTx’s deal with Eli Lilly
4 min read
By Stephanie Vine
November 11, 2025
Interim results from a clinical trial addressing a fatal brain matter disorder suggest that gene therapy could be an effective approach
3 min read
November 11, 2025
Lyell Immunopharma acquires rights to CAR T cell therapy for solid tumors
2 min read
November 11, 2025
Drug manufacturing is under pressure as biologics become more complex. To simplify progress, cell line development is evolving with AI and automation.
7 min read
November 10, 2025
Expanded collaboration between Recipharm Advanced Bio and the UK’s University of Oxford targets vaccine candidates for malaria
4 min read
By Patrick Hyett
November 10, 2025
Pharma must break down data silos to power autonomy, speed, and improved product quality.
3 min read
False